In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology

In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology

FDA approval of anti-CTLA4 in 2011 for melanoma immunotherapy was paradigm shifting and dramatically accelerated cancer immunotherapy research. The investment and effort have been exceptionally large, with a commensurate impressive pace of discovery. Historical and current research has validated the...

Full description

Bibliographic Details
Main Authors:	Chenkai Mao, Michael-Joseph Gorbet, Akansha Singh, Ashish Ranjan, Steven Fiering
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-12-01
Series:	International Journal of Hyperthermia
Subjects:	in situ vaccination cancer immunotherapy nanotechnology nanoparticles
Online Access:	http://dx.doi.org/10.1080/02656736.2020.1810333

Similar Items

Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits
by: Michael-Joseph Gorbet, et al.
Published: (2020-12-01)

Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
by: Amber Kerstetter-Fogle, et al.
Published: (2019-04-01)

Opportunities for Conventional and in Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
by: Rachid Bouzid, et al.
Published: (2020-04-01)

Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
by: Jutaek Nam, et al.
Published: (2021-03-01)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
by: Ruben Victor Huis in ‘t Veld, et al.
Published: (2021-09-01)

Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
by: Yuchen Fan, et al.
Published: (2015-08-01)

Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology
by: Fabiola Urbina, et al.
Published: (2020-07-01)

The Use of Nanobiotechnology in Immunology and Vaccination
by: Reza Keikha, et al.
Published: (2021-01-01)

Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma
by: Won Jong Jin, et al.
Published: (2020-11-01)

Cationic Nanoparticle-Based Cancer Vaccines
by: Jeroen Heuts, et al.
Published: (2021-04-01)

Current applications and future prospects of nanotechnology in cancer immunotherapy
by: Sen Yan, et al.
Published: (2019-09-01)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
by: Nguyen T, et al.
Published: (2014-10-01)

Translational nanoparticle engineering for cancer vaccines
by: Adam J. Grippin, et al.
Published: (2017-10-01)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
by: Isabella Lurje, et al.
Published: (2021-05-01)

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
by: Chang-Gon Kim, et al.
Published: (2021-07-01)

Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma
by: Zhang Y, et al.
Published: (2021-02-01)

Plant Virus Nanoparticle In Situ Cancer Immunotherapies
by: Murray, Abner A.
Published: (2018)

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
by: Han Wu, et al.
Published: (2021-10-01)

Neoantigen vaccine: an emerging tumor immunotherapy
by: Miao Peng, et al.
Published: (2019-08-01)

Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
by: Courtney T. Stump, et al.
Published: (2021-02-01)

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
by: Thai Thanh Hoang Thi, et al.
Published: (2021-04-01)

Bioactive Nanoparticles for Cancer Immunotherapy
by: Suchithra Poilil Surendran, et al.
Published: (2018-12-01)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
by: Elias J. Sayour, et al.
Published: (2018-09-01)

Active immunotherapy of cancer: An overview of therapeutic vaccines
by: Filipić Brankica, et al.
Published: (2019-01-01)

Editorial: Influenza Virus Vaccines and Immunotherapies
by: Arun eKumar, et al.
Published: (2015-11-01)

Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
by: Hector Terán-Navarro, et al.
Published: (2019-02-01)

Herbal gold nanoparticles for attenuating pandemic infection of COVID-19 virus
by: Mousumi Mitra, et al.
Published: (2020-01-01)

Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy
by: Aayushma Gautam, et al.
Published: (2021-09-01)

Preparation, characterization, and in ovo vaccination of dextran-spermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease
by: Firouzamandi M, et al.
Published: (2016-01-01)

Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
by: Hui Cai, et al.
Published: (2019-08-01)

Theranostics Applications of Nanoparticles in Cancer Immunotherapy
by: Yihai Liu, et al.
Published: (2018-11-01)

Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
by: Michael Lim, et al.
Published: (2020-01-01)

Radiation and Anti-Cancer Vaccines: A Winning Combination
by: Alexandra Cadena, et al.
Published: (2018-01-01)

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
by: Maria L. Guevara, et al.
Published: (2020-10-01)

Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8<sup>+</sup> T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System
by: Florian Scheffel, et al.
Published: (2020-03-01)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
by: Marc Mansour, et al.
Published: (2011-08-01)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)

Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy—Current Status and Future Perspectives
by: Ramar Thangam, et al.
Published: (2021-08-01)

Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
by: João Calmeiro, et al.
Published: (2019-09-01)

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
by: Basmah N. Aldosari, et al.
Published: (2021-02-01)